161 related articles for article (PubMed ID: 27258816)
1. Struma Ovarii With Malignant Transformation and Germline KIT Mutation: A Case Report With Review of the Literature.
Ma D; Guseva NV; Dahmoush L; Robinson RA
Int J Gynecol Pathol; 2016 Sep; 35(5):442-7. PubMed ID: 27258816
[TBL] [Abstract][Full Text] [Related]
2. Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.
Tan A; Stewart CJ; Garrett KL; Rye M; Cohen PA
Endocr Pathol; 2015 Dec; 26(4):296-301. PubMed ID: 26362194
[TBL] [Abstract][Full Text] [Related]
3. RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii.
Coyne C; Nikiforov YE
Endocr Pathol; 2010 Jun; 21(2):144-7. PubMed ID: 19898969
[TBL] [Abstract][Full Text] [Related]
4. Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report.
Stanojevic B; Dzodic R; Saenko V; Milovanovic Z; Krstevski V; Radlovic P; Buta M; Rulic B; Todorovic L; Dimitrijevic B; Yamashita S
BMC Cancer; 2012 Jun; 12():224. PubMed ID: 22682753
[TBL] [Abstract][Full Text] [Related]
5. BRAF T1799A mutation occurring in a case of malignant struma ovarii.
Flavin R; Smyth P; Crotty P; Finn S; Cahill S; Denning K; Jinghuan Li ; O'Regan E; O'Leary J; Sheils O
Int J Surg Pathol; 2007 Apr; 15(2):116-20. PubMed ID: 17478764
[TBL] [Abstract][Full Text] [Related]
6. Pathology of Struma Ovarii: A Report of 96 Cases.
Wei S; Baloch ZW; LiVolsi VA
Endocr Pathol; 2015 Dec; 26(4):342-8. PubMed ID: 26374222
[TBL] [Abstract][Full Text] [Related]
7. Follicular variant papillary thyroid carcinoma arising in struma ovarii.
Boutross-Tadross O; Saleh R; Asa SL
Endocr Pathol; 2007; 18(3):182-6. PubMed ID: 18058267
[TBL] [Abstract][Full Text] [Related]
8. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
Roth LM; Miller AW; Talerman A
Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
[TBL] [Abstract][Full Text] [Related]
9. A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations.
Celestino R; Magalhães J; Castro P; Triller M; Vinagre J; Soares P; Sobrinho-Simões M
Histopathology; 2009 Oct; 55(4):482-7. PubMed ID: 19817905
[No Abstract] [Full Text] [Related]
10. It Does Exist! Diagnosis and Management of Thyroid Carcinomas Originating in Struma Ovarii.
Smith LP; Brubaker LW; Wolsky RJ
Surg Pathol Clin; 2023 Mar; 16(1):75-86. PubMed ID: 36739168
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.
Anastasilakis AD; Ruggeri RM; Polyzos SA; Makras P; Molyva D; Campennì A; Gkiomisi A; Balaris C; Fotiadis PP; Tuccari G; Papachatzopoulos S
Metabolism; 2013 Oct; 62(10):1350-6. PubMed ID: 23806737
[TBL] [Abstract][Full Text] [Related]
12. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract][Full Text] [Related]
13. Struma ovarii with atypical features and synchronous primary thyroid cancer: a case report and review of the literature.
Siegel MR; Wolsky RJ; Alvarez EA; Mengesha BM
Arch Gynecol Obstet; 2019 Dec; 300(6):1693-1707. PubMed ID: 31679038
[TBL] [Abstract][Full Text] [Related]
14. BRAF in papillary thyroid carcinoma of ovary (struma ovarii).
Schmidt J; Derr V; Heinrich MC; Crum CP; Fletcher JA; Corless CL; Nosé V
Am J Surg Pathol; 2007 Sep; 31(9):1337-43. PubMed ID: 17721188
[TBL] [Abstract][Full Text] [Related]
15. Follicular carcinoma arising from struma ovarii. A case report.
Limaiem F; Bouraoui S
Pathologica; 2020 Dec; 112(4):224-228. PubMed ID: 33393527
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.
Leong A; Roche PJ; Paliouras M; Rochon L; Trifiro M; Tamilia M
J Clin Endocrinol Metab; 2013 Dec; 98(12):4599-605. PubMed ID: 24217901
[TBL] [Abstract][Full Text] [Related]
17. Malignant struma ovarii: report of a case and review of the literature.
Kostoglou-Athanassiou I; Lekka-Katsouli I; Gogou L; Papagrigoriou L; Chatonides I; Kaldrymides P
Horm Res; 2002; 58(1):34-8. PubMed ID: 12169779
[TBL] [Abstract][Full Text] [Related]
18. The lack of consensus in management of malignant struma ovarii.
González Aguilera B; Guerrero Vázquez R; Gros Herguido N; Sánchez Gallego F; Navarro González E
Gynecol Endocrinol; 2015 Apr; 31(4):258-9. PubMed ID: 25539066
[TBL] [Abstract][Full Text] [Related]
19. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.
Wolff EF; Hughes M; Merino MJ; Reynolds JC; Davis JL; Cochran CS; Celi FS
Thyroid; 2010 Sep; 20(9):981-7. PubMed ID: 20718682
[TBL] [Abstract][Full Text] [Related]
20. Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis.
Roth LM; Karseladze AI
Int J Gynecol Pathol; 2008 Apr; 27(2):213-22. PubMed ID: 18317221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
